aminolevulinic acid has been researched along with Skin Diseases in 88 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of LPDL alone versus LPDL in photodynamic therapy with methylaminolevulinic acid (MAL-LPDL) for acne vulgaris." | 5.13 | Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial. ( Haedersdal, M; Togsverd-Bo, K; Wiegell, SR; Wulf, HC, 2008) |
| "A literature review and results of new clinical trials with regards to photorejuvenation and acne vulgaris treatments with 5-aminolevulinic acid photodynamic therapy are presented." | 4.82 | 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. ( Gold, MH; Goldman, MP, 2004) |
| "Short-contact, full-face 5-aminolevulinic acid photodynamic therapy treatments with a variety of lasers and light sources have shown to be successful in treating all facets of photorejuvenation and the associated actinic keratoses as well as disorders of sebaceous glands, including acne vulgaris." | 4.82 | 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. ( Gold, MH; Goldman, MP, 2004) |
| "In order to evaluate the possible therapeutical effects of reduced glutathione in subjects affected by acquired or congenital heme biosynthesis alterations, two groups of subjects have been considered: the first, of 5 subjects with abnormal lead absorption, the second of 10 patients suffering from porphyria cutanea tarda (PCT)." | 3.68 | [Evaluation of the effects of reduced glutathione in subjects with acquired and congenital changes in heme biosynthesis]. ( Alessio, L; Buizza, P; De Panfilis, G; De Vincentiis, A; Ferioli, A; Leali, C; Pasolini, G, 1992) |
| " Over the following 2 years, some investigators noted and formally reported the continued occurrence of serious adverse events in excess of those described with other approved cutaneous PDT treatments." | 2.79 | Prolonged adverse events following photodynamic therapy: regulatory implications. ( Anderson, SJ; Dixon, AJ; Mazzurco, JD; Steinman, HK, 2014) |
| " It is of concern that this ALA product and lamp could be promoted and used widely in Australia following these reports of significant adverse events and continued lack of TGA approval." | 2.79 | Prolonged adverse events following photodynamic therapy: regulatory implications. ( Anderson, SJ; Dixon, AJ; Mazzurco, JD; Steinman, HK, 2014) |
| "Development of new skin cancers." | 2.79 | Prolonged adverse events following photodynamic therapy: regulatory implications. ( Anderson, SJ; Dixon, AJ; Mazzurco, JD; Steinman, HK, 2014) |
| "The efficacy for lichenoid dermatoses was dependent on the clinical variant (erosive and scleroatrophic were more responsive than hypertrophic)." | 2.78 | A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications. ( Aronson, E; Calzavara-Pinton, PG; Rossi, MT; Sala, R, 2013) |
| "The non-acute porphyrias are porphyria cutanea tarda, erythropoietic protoporphyria, X-linked protoporphyria, and the rare congenital erythropoietic porphyria." | 2.61 | Clinical Guide and Update on Porphyrias. ( Doss, MO; Schuppan, D; Stölzel, U, 2019) |
| "Aminolevulinic acid is a prodrug that is metabolized intracellularly to form the photosensitizing molecule protoporphyrin IX (PpIX)." | 2.42 | Photodynamic therapy and topical aminolevulinic acid: an overview. ( Gupta, AK; Ryder, JE, 2003) |
| "Photodynamic therapy (PDT) for cancer patients has developed into an important new clinical treatment modality in the past 25-years." | 2.40 | 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. ( Berg, K; Giercksky, KE; Kongshaug, M; Moan, J; Nesland, JM; Peng, Q; Warloe, T, 1997) |
| "5-aminolevulinic acid is an early intermediate product in the synthesis of heme." | 2.40 | [Use of 5-aminolevulinic acid in photochemotherapy and fluorescence diagnostics]. ( Bech, O; Berg, K; Moan, J; Peng, Q, 1998) |
| "5-Aminolevulinic acid (5-ALA) is a crucial precursor of heme, which is essential for CII, complex III, complex IV (CIV) and cytochrome c activities." | 1.91 | 5-Aminolevulinic acid bypasses mitochondrial complex I deficiency and corrects physiological dysfunctions in Drosophila. ( Ando, K; Asada, A; Ishii, T; Ishizuka, M; Noguchi, M; Nozawa, N; Saito, T; Shinno, K; Takahashi, K, 2023) |
| "Methyl nicotinate (MN) is a thermogenic and vasodilating substance that facilitates the topical tissue penetration of some compounds." | 1.56 | MAL-associated methyl nicotinate for topical PDT improvement. ( Bagnato, VS; Buzza, HH; Ciol, H; Inada, NM; Leite, IS; Romano, RA; Stringasci, MD, 2020) |
| "Sarcoidosis is a systemic granulomatous disease." | 1.35 | Photodynamic therapy as an alternative treatment for cutaneous sarcoidosis. ( Bieber, T; Novak, N; Wilsmann-Theis, D, 2008) |
| "The main adverse effect in PDT treatment is pain." | 1.34 | Pain and photodynamic therapy. ( Brogaard, HM; Jemec, GB; Lindeburg, KE, 2007) |
| " at the dosage of 600-1200 mg for a variable period of 3-5 days in the first group, for 7-10 days in the patients with PCT." | 1.28 | [Evaluation of the effects of reduced glutathione in subjects with acquired and congenital changes in heme biosynthesis]. ( Alessio, L; Buizza, P; De Panfilis, G; De Vincentiis, A; Ferioli, A; Leali, C; Pasolini, G, 1992) |
| "The porphyrias are caused by hereditary defects in the synthesis of heme." | 1.27 | The porphyrias. ( Rosen, T; Sekula, SA; Tschen, JA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (11.36) | 18.7374 |
| 1990's | 5 (5.68) | 18.2507 |
| 2000's | 34 (38.64) | 29.6817 |
| 2010's | 31 (35.23) | 24.3611 |
| 2020's | 8 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| do Amparo Manoel, C | 1 |
| de Sousa Mariano, S | 1 |
| da Silva Ramos, E | 1 |
| Paolillo, FR | 1 |
| de Aro, AA | 1 |
| Mendes, C | 1 |
| Venturini, LM | 1 |
| Silveira, PCL | 1 |
| Bagnato, VS | 2 |
| de Andrade, TAM | 1 |
| Mackay, AM | 1 |
| Yu, Y | 1 |
| Li, J | 2 |
| Zou, Y | 1 |
| Yin, R | 1 |
| Nozawa, N | 1 |
| Noguchi, M | 1 |
| Shinno, K | 1 |
| Saito, T | 2 |
| Asada, A | 1 |
| Ishii, T | 1 |
| Takahashi, K | 1 |
| Ishizuka, M | 1 |
| Ando, K | 1 |
| Bhatia, N | 1 |
| Monfrecola, G | 1 |
| Megna, M | 1 |
| Rovati, C | 1 |
| Arisi, M | 2 |
| Rossi, M | 1 |
| Calzavara-Pinton, I | 1 |
| Fabbrocini, G | 1 |
| Calzavara-Pinton, P | 2 |
| Stringasci, MD | 1 |
| Ciol, H | 1 |
| Romano, RA | 1 |
| Buzza, HH | 1 |
| Leite, IS | 1 |
| Inada, NM | 1 |
| Liu, D | 1 |
| Zhao, S | 1 |
| Chen, M | 1 |
| Wu, L | 1 |
| Dalal, KS | 1 |
| Bridgeman, MB | 1 |
| Wen, X | 1 |
| Li, Y | 1 |
| Hamblin, MR | 1 |
| Theresia, C | 1 |
| Zheng, J | 1 |
| Chen, XY | 1 |
| Alique-García, S | 1 |
| Company-Quiroga, J | 1 |
| Horcajada-Reales, C | 1 |
| Echeverría-García, B | 1 |
| Tardío-Dovao, JC | 1 |
| Borbujo, J | 1 |
| Siegel, DM | 1 |
| Nguyen, K | 1 |
| Khachemoune, A | 1 |
| Lim, CM | 1 |
| Grillo, M | 1 |
| Harrison, P | 1 |
| Nguyen, AM | 1 |
| Gordon, L | 1 |
| Stölzel, U | 1 |
| Doss, MO | 1 |
| Schuppan, D | 1 |
| Basset-Seguin, N | 3 |
| Anderson, SJ | 1 |
| Steinman, HK | 1 |
| Mazzurco, JD | 1 |
| Dixon, AJ | 1 |
| Wang, D | 1 |
| Liang, J | 1 |
| Xu, J | 1 |
| Chen, L | 1 |
| Kürten, V | 1 |
| Neumann, NJ | 2 |
| Frank, J | 1 |
| Haedersdal, M | 2 |
| Erlendsson, AM | 1 |
| Paasch, U | 1 |
| Anderson, RR | 2 |
| Juhasz, ML | 1 |
| Levin, MK | 1 |
| Marmur, ES | 1 |
| Wilsmann-Theis, D | 1 |
| Bieber, T | 1 |
| Novak, N | 1 |
| Yang, J | 1 |
| Xia, Y | 1 |
| Liu, X | 1 |
| Jiang, S | 1 |
| Xiong, L | 1 |
| Piergiacomo, CP | 1 |
| Mariachiara, A | 1 |
| Sereni, E | 1 |
| Elena, S | 1 |
| Ortel, B | 1 |
| Bernhard, O | 1 |
| O'Neill, J | 1 |
| Fien, S | 1 |
| Zeitouni, NC | 1 |
| Tyrrell, JS | 1 |
| Campbell, SM | 1 |
| Curnow, A | 2 |
| Li, Q | 1 |
| Jiao, B | 1 |
| Long, HA | 1 |
| Penrose, C | 1 |
| Mercer, SE | 1 |
| Shim-Chang, H | 1 |
| Oh, EK | 1 |
| Jin, SE | 1 |
| Kim, JK | 1 |
| Park, JS | 1 |
| Park, Y | 1 |
| Kim, CK | 1 |
| Tyrrell, J | 1 |
| Thorn, C | 1 |
| Shore, A | 1 |
| Campbell, S | 1 |
| Hasegawa, T | 1 |
| Suga, Y | 1 |
| Mizuno, Y | 1 |
| Haruna, K | 1 |
| Ikeda, S | 1 |
| Moore, MM | 1 |
| Reyna, C | 1 |
| Hope, RH | 1 |
| Ibbotson, S | 2 |
| Gomes, J | 1 |
| Ventura, F | 1 |
| da Luz Duarte, M | 1 |
| Brito, C | 1 |
| Li, X | 1 |
| Zhou, ZP | 1 |
| Hu, L | 1 |
| Zhang, WJ | 1 |
| Li, W | 1 |
| Dragicevic-Curic, N | 1 |
| Fahr, A | 1 |
| Calzavara-Pinton, PG | 3 |
| Rossi, MT | 2 |
| Aronson, E | 1 |
| Sala, R | 3 |
| Valentine, RM | 1 |
| Ibbotson, SH | 2 |
| Wood, K | 1 |
| Brown, CT | 1 |
| Moseley, H | 2 |
| Gupta, AK | 1 |
| Ryder, JE | 1 |
| Kormeili, T | 1 |
| Yamauchi, PS | 1 |
| Lowe, NJ | 1 |
| Gold, MH | 2 |
| Goldman, MP | 1 |
| Akita, Y | 1 |
| Kozaki, K | 1 |
| Nakagawa, A | 1 |
| Ito, S | 1 |
| Tamada, Y | 2 |
| Fujiwara, S | 1 |
| Nishikawa, N | 1 |
| Uchida, K | 1 |
| Yoshikawa, K | 1 |
| Noguchi, T | 1 |
| Miyaishi, O | 1 |
| Shimozato, K | 1 |
| Saga, S | 1 |
| Matsumoto, Y | 2 |
| Thissen, MR | 1 |
| Kuijpers, DI | 1 |
| Neumann, HA | 1 |
| Larkö, O | 1 |
| Wennberg, AM | 2 |
| Foley, P | 3 |
| Fergin, P | 1 |
| Takeda, H | 1 |
| Kaneko, T | 1 |
| Harada, K | 1 |
| Matsuzaki, Y | 1 |
| Nakano, H | 1 |
| Hanada, K | 1 |
| Mikasa, K | 1 |
| Watanabe, D | 1 |
| Kondo, C | 1 |
| Bäumler, W | 1 |
| Ackermann, G | 1 |
| Abels, C | 2 |
| Szeimies, RM | 4 |
| Gilaberte, Y | 1 |
| Serra-Guillén, C | 1 |
| de las Heras, ME | 1 |
| Ruiz-Rodríguez, R | 1 |
| Fernández-Lorente, M | 1 |
| Benvenuto-Andrade, C | 1 |
| González-Rodríguez, S | 1 |
| Guillén-Barona, C | 1 |
| Silva, JN | 1 |
| Filipe, P | 1 |
| Morlière, P | 1 |
| Mazière, JC | 1 |
| Freitas, JP | 1 |
| Cirne de Castro, JL | 1 |
| Santus, R | 1 |
| Bryld, LE | 1 |
| Jemec, GB | 2 |
| Biron, J | 1 |
| Ghaffar, SA | 1 |
| Clements, SE | 1 |
| Lear, JT | 1 |
| Braathen, LR | 1 |
| Bissonnette, R | 1 |
| Pariser, D | 1 |
| Roelandts, R | 1 |
| Morton, CA | 3 |
| Venturini, M | 1 |
| Lindeburg, KE | 1 |
| Brogaard, HM | 1 |
| Redbord, KP | 1 |
| Hanke, CW | 1 |
| Togsverd-Bo, K | 1 |
| Wiegell, SR | 1 |
| Wulf, HC | 1 |
| Ibraham, NG | 1 |
| Friedland, ML | 1 |
| Levere, RD | 1 |
| Bissell, DM | 1 |
| Stewart, PM | 1 |
| Hensley, WJ | 1 |
| Romeo, G | 1 |
| Waldenström, J | 1 |
| Magnin, PH | 1 |
| del C Batlle, AM | 1 |
| de Xifra, EA | 1 |
| Lenczner, M | 1 |
| Parera, VE | 1 |
| Stella, AM | 1 |
| Hines, JD | 1 |
| Peng, Q | 2 |
| Warloe, T | 1 |
| Berg, K | 2 |
| Moan, J | 2 |
| Kongshaug, M | 1 |
| Giercksky, KE | 1 |
| Nesland, JM | 1 |
| Fritsch, C | 2 |
| Goerz, G | 1 |
| Ruzicka, T | 2 |
| Bech, O | 1 |
| Dierickx, CC | 1 |
| Goldenhersh, M | 1 |
| Dwyer, P | 1 |
| Stratigos, A | 1 |
| Mihm, M | 1 |
| Lehmann, P | 1 |
| Fischer, F | 1 |
| Dickson, EF | 1 |
| Pottier, RH | 1 |
| Wieland, H | 1 |
| Brown, SB | 2 |
| Collins, S | 1 |
| Jenkinson, H | 1 |
| Kurwa, H | 1 |
| Langmack, K | 1 |
| McKenna, K | 1 |
| Pearse, AD | 1 |
| Stringer, M | 1 |
| Taylor, DK | 1 |
| Wong, G | 1 |
| Rhodes, LE | 1 |
| Karrer, S | 2 |
| Wimmershoff, MB | 1 |
| Landthaler, M | 2 |
| Taylor, EL | 1 |
| Ferioli, A | 1 |
| De Vincentiis, A | 1 |
| Buizza, P | 1 |
| Pasolini, G | 1 |
| Leali, C | 1 |
| De Panfilis, G | 1 |
| Alessio, L | 1 |
| Sekula, SA | 1 |
| Tschen, JA | 1 |
| Rosen, T | 1 |
| Chan, KM | 1 |
| Ladenson, JH | 1 |
| Vaidya, HC | 1 |
| Kanan, R | 1 |
| Siepker, LJ | 1 |
| Kramer, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fluorescence and Thermal Imaging of the Skin Before and During Photodynamic Therapy[NCT03167762] | 18 participants (Actual) | Interventional | 2017-06-22 | Completed | |||
| Evaluation of the Formulation of 5-aminolevulinic Acid With Dimethylsulfoxide in Photodynamic Therapy for Treatment of Actinic Keratosis[NCT01459393] | Phase 3 | 137 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| A Randomized Half-side Comparative Trial of Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic Therapy in Organ Transplant Recipients With Multiple Actinic Keratoses of the Scalp or Forehead[NCT01898936] | 12 participants (Actual) | Interventional | 2013-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
38 reviews available for aminolevulinic acid and Skin Diseases
| Article | Year |
|---|---|
The evolution of clinical guidelines for antimicrobial photodynamic therapy of skin.
Topics: Aminolevulinic Acid; Anti-Bacterial Agents; Humans; Photochemotherapy; Photosensitizing Agents; Skin | 2022 |
The Interventions to Minimize Pain During Photodynamic Therapy With 5-Aminolevulinic Acid for the Treatment of Cutaneous Diseases.
Topics: Aminolevulinic Acid; Humans; Levulinic Acids; Pain; Photochemotherapy; Skin Diseases; United States | 2023 |
A Critical Reappraisal of Off-Label Use of Photodynamic Therapy for the Treatment of Non-Neoplastic Skin Conditions.
Topics: Acne Vulgaris; Aminolevulinic Acid; Cosmetic Techniques; Humans; Lichen Sclerosus et Atrophicus; Off | 2021 |
The application of physical pretreatment in photodynamic therapy for skin diseases.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Neoplasm Recurrence, Local; Photochemotherapy; Phot | 2021 |
Photodynamic therapy in dermatology beyond non-melanoma cancer: An update.
Topics: Acne Vulgaris; Aminolevulinic Acid; Collagen; Humans; Photochemotherapy; Photosensitizing Agents; Po | 2017 |
Topical ALA-PDT as alternative therapeutic option in treatment-recalcitrant dermatosis: Report of 4 cases.
Topics: Acne Vulgaris; Adolescent; Adult; Aged, 80 and over; Aminolevulinic Acid; Condylomata Acuminata; Fem | 2017 |
An update on topical photodynamic therapy for clinical dermatologists.
Topics: Administration, Topical; Aminolevulinic Acid; Carcinoma, Basal Cell; Dermatologists; Humans; Light; | 2019 |
Clinical Guide and Update on Porphyrias.
Topics: Aminolevulinic Acid; Gastroenterology; Gastrointestinal Diseases; Humans; Nervous System Diseases; P | 2019 |
[PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Kerat | 2013 |
[Diagnosis of the porphyrias : From A (as in aminolevulinic acid) to Z (as in zinc protoporphyrin)].
Topics: Aminolevulinic Acid; Biomarkers; Diagnosis, Differential; Porphyrias; Protoporphyrins; Reproducibili | 2016 |
Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: A critical review from basics to current clinical status.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Anesthetics; Animals; Cicatrix; Controlled Clinical | 2016 |
The Two Faces of Fractionated Photodynamic Therapy: Increasing Efficacy With Light Fractionation or Adjuvant Use of Fractional Laser Technology.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Clinical Trials as Topic; Combined Modality Therapy; | 2016 |
A critical reappraisal of off-label indications for topical photodynamic therapy with aminolevulinic acid and methylaminolevulinate.
Topics: Aminolevulinic Acid; Humans; Photochemotherapy; Rejuvenation; Skin Diseases; Skin Neoplasms | 2010 |
Liposomes in topical photodynamic therapy.
Topics: Aminolevulinic Acid; Drug Carriers; Humans; Light; Liposomes; Mesoporphyrins; Photochemotherapy; Pho | 2012 |
Photodynamic therapy and topical aminolevulinic acid: an overview.
Topics: Administration, Topical; Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Sk | 2003 |
Topical photodynamic therapy in clinical dermatology.
Topics: Adult; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Keratosis; Phot | 2004 |
5-aminolevulinic acid photodynamic therapy: where we have been and where we are going.
Topics: Acne Vulgaris; Administration, Cutaneous; Aminolevulinic Acid; Clinical Trials as Topic; Humans; Ker | 2004 |
[The wider application of photodynamic therapy in dermatology].
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Dermatology; Humans; Keratosis; Photoch | 2005 |
Photodynamic therapy.
Topics: Administration, Topical; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Cryotherapy; Fluorour | 2005 |
Pain, pain relief and other practical issues in photodynamic therapy.
Topics: Administration, Topical; Aminolevulinic Acid; Analgesia; Humans; Pain; Patient Education as Topic; P | 2005 |
Photodynamic therapy of dermatoses other than non-melanoma skin cancer.
Topics: Administration, Topical; Aminolevulinic Acid; Humans; Keratosis; Photochemotherapy; Photosensitizing | 2005 |
[Fluorescence diagnosis in dermatology].
Topics: Aminolevulinic Acid; Image Processing, Computer-Assisted; Optical Imaging; Protoporphyrins; Skin Dis | 2003 |
[Photodynamic therapy in dermatology].
Topics: Aminolevulinic Acid; Esthetics; Forecasting; Humans; Infrared Rays; Low-Level Light Therapy; Photoch | 2006 |
Photodynamic therapies: principles and present medical applications.
Topics: Aminolevulinic Acid; Bowen's Disease; Clinical Trials as Topic; Humans; Light; Lipoproteins, LDL; Ma | 2006 |
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.
Topics: Aminolevulinic Acid; Australia; Basal Cell Nevus Syndrome; Bowen's Disease; Carcinoma, Basal Cell; C | 2007 |
Photodynamic therapy: update 2006. Part 2: Clinical results.
Topics: Aminolevulinic Acid; Drug Approval; Humans; Photochemotherapy; Photosensitizing Agents; Randomized C | 2007 |
Heme metabolism in erythroid and hepatic cells.
Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; Coproporphyrinogen Oxidase; Erythrocytes; Erythro | 1983 |
Laboratory evaluation in porphyria.
Topics: Acute Disease; Aminolevulinic Acid; Animals; Carrier State; Chemistry, Clinical; Diagnosis, Differen | 1982 |
The hepatic porphyrias.
Topics: 5-Aminolevulinate Synthetase; Acute Disease; Adolescent; Adult; Aminolevulinic Acid; Chemical Phenom | 1980 |
The porphyrias--a review.
Topics: Acute Disease; Aged; Alcoholism; Aminolevulinic Acid; Feces; Female; Heme; Humans; Iron; Liver Disea | 1981 |
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Topics: Aminolevulinic Acid; Forecasting; Heme; Humans; Neoplasms; Photochemotherapy; Protoporphyrins; Resea | 1997 |
Photodynamic therapy in dermatology.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cel | 1998 |
[Use of 5-aminolevulinic acid in photochemotherapy and fluorescence diagnostics].
Topics: Aminolevulinic Acid; Fluorescence; Heme; Humans; Photochemotherapy; Protoporphyrins; Skin Diseases; | 1998 |
Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer.
Topics: Acne Vulgaris; Aminolevulinic Acid; Humans; Lymphoma, T-Cell; Photochemotherapy; Photosensitizing Ag | 2002 |
Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Health Care Costs; Humans; Keratosis; L | 2002 |
The advantages of aminolevulinic acid photodynamic therapy in dermatology.
Topics: Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Skin Diseases | 2002 |
Non-oncologic indications for ALA-PDT.
Topics: Aminolevulinic Acid; Humans; Lichen Sclerosus et Atrophicus; Papillomavirus Infections; Photochemoth | 2002 |
The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Keratosis; Photochemotherapy; P | 2002 |
5 trials available for aminolevulinic acid and Skin Diseases
| Article | Year |
|---|---|
Prolonged adverse events following photodynamic therapy: regulatory implications.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Australia; Biopsy; Early Termination of Clinical Trial | 2014 |
A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications.
Topics: Acne Vulgaris; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Italy; Light; Ma | 2013 |
A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Italy; Light; Male; | 2013 |
Topical photodynamic therapy for dermatologic disorders: results and complications.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Dermatitis, Phototox | 2007 |
Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial.
Topics: Acne Vulgaris; Adult; Aminolevulinic Acid; Edema; Erythema; Female; Fluorescence; Humans; Laser Ther | 2008 |
45 other studies available for aminolevulinic acid and Skin Diseases
| Article | Year |
|---|---|
Photobiomodulation and photodynamic therapy applied after electrocauterization for skin healing optimization in rats.
Topics: Aminolevulinic Acid; Animals; Electrocoagulation; Female; Photochemotherapy; Rats; Rats, Wistar; Ski | 2022 |
5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) for acneform rash induced by erlotinib: A case report.
Topics: Acne Vulgaris; Aminolevulinic Acid; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydroc | 2022 |
5-Aminolevulinic acid bypasses mitochondrial complex I deficiency and corrects physiological dysfunctions in Drosophila.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Animals; Drosophila; Heme Oxygenase-1; Lactates; Mitoch | 2023 |
MAL-associated methyl nicotinate for topical PDT improvement.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Cell Line; Cell Survival; Humans; Male; NAD; | 2020 |
Drugs to treat dermatologic disorders.
Topics: Aminolevulinic Acid; Antibodies, Monoclonal, Humanized; Calcitriol; Dermatologic Agents; Humans; Ski | 2017 |
Idiopathic elastosis perforans serpiginosa with satisfactory response after 5-ALA photodynamic therapy.
Topics: Adult; Aminolevulinic Acid; Female; Humans; Photochemotherapy; Photosensitizing Agents; Skin Disease | 2018 |
Let there be light: update on coding for photodynamic therapy and lasers.
Topics: Aminolevulinic Acid; Humans; Laser Therapy; Photochemotherapy; Photosensitizing Agents; Skin Disease | 2018 |
Photodynamic therapy: A real-world analysis of outcomes of photodynamic therapy in an Australian tertiary dermatology clinic.
Topics: Adult; Aged; Ambulatory Care; Aminolevulinic Acid; Australia; Cohort Studies; Dermatology; Female; H | 2019 |
Effective treatment of d-penicillamine induced elastosis perforans serpiginosa with ALA-PDT.
Topics: Adult; Aminolevulinic Acid; Chelating Agents; Humans; Male; Penicillamine; Photochemotherapy; Photos | 2015 |
Photodynamic therapy as an alternative treatment for cutaneous sarcoidosis.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Ear, External; Eye; Female; Humans; Male; Phot | 2008 |
Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines.
Topics: Aminolevulinic Acid; Cell Death; Cell Line; Deferoxamine; Drug Synergism; Fibroblasts; Humans; Iron | 2010 |
Drug-induced photosensitivity.
Topics: Aminolevulinic Acid; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2009 |
ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report.
Topics: Aminolevulinic Acid; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pseudoly | 2010 |
The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans | 2010 |
Pseudoepitheliomatous hyperplasia treated by photodynamic therapy with variable irradiation dose and concentration of photosensitizer.
Topics: Adult; Aminolevulinic Acid; Epidermis; Female; Humans; Hyperplasia; Middle Aged; Photochemotherapy; | 2011 |
Photodynamic therapy for the treatment of cutaneous sarcoidosis.
Topics: Aminolevulinic Acid; Black or African American; Esthetics; Facial Dermatoses; Female; Follow-Up Stud | 2011 |
Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Cations; Drug Compounding; Drug Stability; In | 2011 |
Oxygen saturation and perfusion changes during dermatological methylaminolaevulinate photodynamic therapy.
Topics: Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Male; Microcirculation; Oxygen; Photochemoth | 2011 |
Photodynamic therapy using intense pulsed light for cutaneous sarcoidosis.
Topics: Administration, Topical; Aminolevulinic Acid; Female; Humans; Middle Aged; Photochemotherapy; Sarcoi | 2012 |
Severe cutaneous reaction to photodynamic therapy with blue light.
Topics: Aminolevulinic Acid; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemothe | 2011 |
Oxygen saturation and perfusion changes during photodynamic therapy: use of noninvasive monitoring.
Topics: Aminolevulinic Acid; Female; Humans; Male; Oxygen; Photochemotherapy; Photosensitizing Agents; Skin | 2011 |
Colloid milium successfully treated with MAL-PDT.
Topics: Aminolevulinic Acid; Colloids; Facial Dermatoses; Humans; Male; Middle Aged; Photochemotherapy; Phot | 2013 |
Apoptotic cell death induced by 5-aminolaevulinic acid-mediated photodynamic therapy of hypertrophic scar-derived fibroblasts.
Topics: Adolescent; Adult; Aminolevulinic Acid; Apoptosis; Cells, Cultured; Child; Cicatrix, Hypertrophic; F | 2014 |
Modelling fluorescence in clinical photodynamic therapy.
Topics: Aminolevulinic Acid; Humans; Models, Theoretical; Monte Carlo Method; Photobleaching; Photochemother | 2013 |
Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cyc | 2004 |
Practical aspects of methyl aminolaevulinate photodynamic therapy.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Dose-Response Relationship, Drug; Drug Admini | 2005 |
Methyl aminolaevulinate photodynamic therapy in practice: treatment protocol.
Topics: Administration, Topical; Aminolevulinic Acid; Clinical Protocols; Dose-Response Relationship, Drug; | 2005 |
Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid.
Topics: Adolescent; Aminolevulinic Acid; Female; Humans; Photochemotherapy; Photosensitizing Agents; Pseudol | 2005 |
Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma.
Topics: Administration, Topical; Aminolevulinic Acid; Female; Humans; Middle Aged; Photochemotherapy; Photos | 2005 |
[Dynamic phototherapy in dermatology: current uses and future perspectives].
Topics: Aminolevulinic Acid; Humans; Photosensitizing Agents; Phototherapy; Porphyrins; Skin Diseases | 2006 |
The bacterial flora of the skin surface following routine MAL-PDT.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Colony Count, Microbial; Female; Humans; Male; | 2006 |
A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy.
Topics: Administration, Topical; Adult; Aminolevulinic Acid; Cytokines; Female; Growth Substances; Humans; O | 2006 |
Epidermoid cysts mimicking recurrence of superficial basal cell carcinoma following photodynamic therapy.
Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Diagnosis, Differential; Epidermal Cyst; Female; Humans; | 2007 |
Pain and photodynamic therapy.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Male; Middle Aged; Pain; Pain Measurem | 2007 |
An acute attack of variegate porphyria complicated by severe autonomic neuropathy.
Topics: Acute Disease; Adult; Aminolevulinic Acid; Autonomic Nervous System Diseases; Female; Humans; Porpho | 1981 |
Acquired and inherited porphyria: clinical and biochemical features.
Topics: Aminolevulinic Acid; Chromatography, Thin Layer; Erythrocytes; Female; Humans; Male; Pedigree; Porph | 1982 |
Effects of alcohol on inborn errors of metabolism: porphyria cutanea tarda and hemochromatosis.
Topics: Alcoholism; Aminolevulinic Acid; Coproporphyrins; Ethanol; Hemochromatosis; Hemosiderosis; Humans; I | 1980 |
Photodynamic therapy for nevus sebaceus with topical delta-aminolevulinic acid.
Topics: Administration, Topical; Adult; Aminolevulinic Acid; Female; Hamartoma; Humans; Photochemotherapy; P | 1999 |
[Photodiagnostic tests. 3: Fluorescence diagnosis with delta-aminolevulinic acid-induced porphyrins (FDAP) in dermatology].
Topics: Aminolevulinic Acid; Fluorescence; Humans; Porphyrins; Sensitivity and Specificity; Skin; Skin Disea | 2000 |
An affordable, portable fluorescence imaging device for skin lesion detection using a dual wavelength approach for image contrast enhancement and aminolaevulinic acid-induced protoporphyrin IX. Part I. Design, spectral and spatial characteristics.
Topics: Aminolevulinic Acid; Equipment Design; Humans; Image Processing, Computer-Assisted; Photosensitizing | 2001 |
Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Photochemotherapy; Photosensitizing Agents; Recurrence; S | 2002 |
[Evaluation of the effects of reduced glutathione in subjects with acquired and congenital changes in heme biosynthesis].
Topics: Aminolevulinic Acid; Coproporphyrins; Glutathione; Heme; Humans; Lead Poisoning; Porphyrias; Porphyr | 1992 |
The porphyrias.
Topics: Adolescent; Adult; Aminolevulinic Acid; beta Carotene; Bloodletting; Carotenoids; Child; Child, Pres | 1986 |
Washington University case conference. Dual porphyria--an underdiagnosed entity?
Topics: Aminolevulinic Acid; Coproporphyrins; Diagnosis, Differential; Feces; Flavoproteins; Humans; Male; M | 1987 |
Protoporphyrin accumulation by mitogen stimulated lymphocytes and protoporphyrinogen oxidase activity in patients with porphyria variegata and erythropoietic protoporphyria: evidence for deficiency of protoporphyrinogen oxidase and ferrochelatase in both
Topics: Adult; Aminolevulinic Acid; Child; Edetic Acid; Ferrochelatase; Flavoproteins; Humans; Iron; Liver D | 1985 |